Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii.
Lan X, Qin S, Liu H, Guo M, Zhang Y, Jin X, Duan X, Sun M, Liu Z, Wang W, Zheng Q, Liao X, Chen J, Kang Y, Xie Y, Song X.
Lan X, et al. Among authors: liao x.
J Nanobiotechnology. 2024 Mar 30;22(1):138. doi: 10.1186/s12951-024-02373-z.
J Nanobiotechnology. 2024.
PMID: 38555444
Free PMC article.